Answer to the challenge No.2
About the Authors
O. N. Brodskaya
Pirogov Russian National Research Medical University (Pirogov Medical University), Healthcare Ministry of Russia
Russian Federation
Competing Interests:
Russian Federation
Olga N. Brodskaya - Candidate of Medicine, Associate Professor, Department of Hospital Internal Medicine, Pediatric Faculty, Pirogov Russian National Research Medical University (Pirogov Medical University), Healthcare Ministry of Russia.
Ostrovityanova ul. 1, Moscow, 117997
tel.: (916) 614-56-96
SPIN code: 8394-5765
Competing Interests:
None
I. N. Butyugina
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia; D.D. Pletnev City Teaching Hospital, Moscow Healthcare Department
Russian Federation
Competing Interests:
Russian Federation
Irina N. Butyugina - Pulmonologist, Pulmonology Department for patients with cystic fibrosis, D.D. Pletnev City Teaching Hospital, Moscow Healthcare Department; Researcher, Cystic Fibrosis Laboratory, Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia.
Orehovyy bul'var 28, Moscow, 115682; ul. Odinnadtsataya Parkovaya 32, Moscow, 105077
tel.: (926) 366-95-36
Competing Interests:
None
O. Yu. Gracheva
Federal Pulmonology Research Institute, Federal Medical and Biological Agency of Russia
Russian Federation
Competing Interests:
Russian Federation
Olga Yu. Gracheva - Head of the Pulmonology Department for patients with cystic fibrosis, D.D. Pletnev City Teaching Hospital, Moscow Healthcare Department.
Orehovyy bul'var 28, Moscow, 115682
tel.: (916) 283-06-16
Competing Interests:
None
References
1. Daley C.L., Iaccarino J.M., Lange C. et al. Treatment of nontu-berculous mycobacterial pulmonary disease: an official ATS/ERS/ ESCMID/IDSA clinical practice guideline. Eur. Respir. J. 2020; 56 (1): 2000535. DOI: 10.1183/13993003.00535-2020.
2. Russian Respiratory Society. [Mycobacteriosis of the respiratory system: clinical guidelines]. Available at: https://spulmo.ru/upload/kr/Microbakterioz_2022.pdf (in Russian).
3. Kartalija M., Ovrutsky A.R., Bryan C.L. et al. Patients with nontuber-culous mycobacterial lung disease exhibit unique body and immune phenotypes. Am. J. Respir. Crit. Care Med. 2013; 187 (2): 197-205. DOI: 10.1164/rccm.201206-1035OC.
4. Griffith D.E., Aksamit T., Brown-Elliott B.A. et al. An official ATS/ IDSA statement: diagnosis, treatment, and prevention of nontuber-culous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 2007; 175 (4): 367-416. DOI: 10.1164/rccm.200604-571ST.
5. Kwak N., Lee J.H., Kim H.J. et al. New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes. BMC Pulm. Med. 2020; 20 (1): 293. DOI: 10.1186/s12890-020-01331-3.
6. Chuchalin A.G., ed. [Respiratory medicine: a guide in 3 vol.]. 2nd edn. Moscow: Litterra; 2017 (in Russian).
Review
For citations:
Answer to the challenge No.2. PULMONOLOGIYA. 2022;32(6):928-930. (In Russ.)
Views:
226
Email this article 